A New Way to Treat Brain Diseases at Home Using Non-Invasive Brain Stimulation
November 5, 2020 (PST) @ 5:30 pm – 6:30 pm PST
The COVID-19 pandemic has highlighted a needs for non-invasive, remote approaches to patient care. Learn how companies like Neuroelectrics are working to bring non-invasive brain stimulation into the home. Join Dr. Eric Grigsby, CEO and Founder of Neurovations, and Ana Maiques, CEO and Co-founder of Neuroelectrics for an engaging conversation on new ways to treat brain diseases at home.
In May 2020, Neuroelectrics received FDA approval for a clinical trial of at-home brain stimulation therapy via telemedicine for patients with Major Depressive Disorder (MDD). An additional trial with Boston Children’s Hospital (IDE G160208) is already underway, studying the therapy for treatment-resistant epilepsy.
Dr. Eric Grigsby, MD, MBA is Chief Executive Officer and Founder of Neurovations. For over three decades, Dr. Grigsby has focused his clinical career on academia and private practice. Today, in addition to busy practices, surgery centers, education divisions and labs, Dr. Grigsby guides research and innovation at Neurovations.
Dr Grigsby has been seminally involved in the majority of the interventional devices and therapies used in the field of pain management. He guides start-ups and industry-leading companies through the innovation, discovery and clinical research process which includes access to sites for clinical investigation in pain and neurologic disease.
The Neurovations Education division holds world-class programs and ACCME accredited conferences in Pain and Neuroscience. Additionally, Neurovations Education helps companies and clinicians develop and learn surgical therapies. Dr. Grigsby’s non-profit foundation, HealthRoots, is committed to community health and innovation for underserved patients and communities.
Originally from Knoxville, Tennessee, Dr. Grigsby is a graduate of Brown University with an undergraduate degree in Biology and Economics. He completed medical school at Boston University School of Medicine and residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Master’s in Business Administration in Health Sector Management from Duke University.
Ana Maiques (born 1973) is a Spanish entrepreneur and business executive. She is CEO of Neuroelectrics, Spanish Barcelona-based company which has an office in Cambridge, Massachusetts. It produces devices designed to stimulate and treat the brain. Maiques graduated from the University of North London where she studied European Economics and Social Studies. In 2000, she co-founded and headed Starlab, Barcelona, a neuroscience research company. She developed revolutionary technologies in the fields of space and neuroscience. In 2014, Maiques won third prize in the European Commission’s Women Innovators Contest for her entrepreneurial vision in promoting Starlab as an innovative company of scientific excellence. Now CEO at Neuroelectrics, a Starlab spin-off, Maiquess has developed medical devices for the brain. These are computer applications that are able to help patients overcome chronic pain and depression. Ana Maiques and her husband, Giulio Ruffini, began working in Barcelona for the original Belgian company Starlab. In the year 2000, when the Belgian company declared bankruptcy they, along with Manel Adell, took over the Spanish subsidiary in an attempt to develop marketable products. Maiques is now aiming for Neuroelectrics to become a “leading company in the diagnosis and treatment of brain disorders and diseases of the central nervous system,” while the Spanish Starlab will continue to undertake neuroscience research. In April 2015, Neuroelectrics won the Bupa Startup Stage at Wired Health 2015.